Monday, 23rd February 2015
Yulia Aspinall considers the role of competitive intelligence in developing and marketing new drugs, and how information from FreePint can help information professionals harvest intelligence from sources such as specialist drug development databases, news platforms and knowledge software.
It can take over 10 years and around $1 billion to develop a single new drug from its discovery in the lab to it being available for the treatment of patients. A key challenge for any biopharmaceutical company is therefore how to develop and market a drug which produces revenue that exceeds the research and development (R&D) cost.
To market a new drug two important decisions have to be reached:
Market authorisation can be obtained by convincing regulatory agencies like the European Medicine Agency (EMA) in Europe and the Food and Drug Administration (FDA) in the US about the efficacy and safety of the drug. However, in order to ensure market uptake, a "value for money" assessment is increasingly being demanded by cash-strapped healthcare systems.
The market access strategy provided is generally specific for each market assessment. This process requires comparative market analysis, and a large number of market characteristics have to be taken into consideration, including current therapy standards, expected number of target patients, price and more.
CI to Support Market Access Strategies
Competitive intelligence (CI), as a process of gathering, analysing and interpreting internal and external information and intelligence on competitors and the competitive environment, can undoubtedly support the requirement of those who develop market access strategies.
Relevant to market access, comparative information and intelligence which is routinely collected and analysed by CI professionals, could be divided into four pillars:
Figure 1: Information requirements for market access
Updates and Reviews from FreePint
FreePint often provides updates and reviews of information resources for competitive intelligence professionals, which can be also be used for harvesting and analysis of relevant market access information.
Related Blog items:
Related Subscription Articles:
Related Subscription Reports:
Document the value chain, and transform the way you think about, manage and report on your product portfolio and your information service contributions to your organisation goals.
Focus on Value Chain
Risk assessment is a required process for a healthy information department. It gauges the ability of your services, team, portfolio and overall value to withstand stress.
Focus on Risk Assessment
Sorry, there seems to be a problem with Webinar and Community listings. Please let us know, by email to email@example.com. Thank you.
Our proven processes, resources and guidance will help your team make the shift from transaction centre to strategic asset.
Designed around the most common challenges and pain points for time- and resource-strapped information teams
Supercharge remote productivity and value
Holistic content portfolio management
Future-proof your information service
A tailored overview of our research and active discussion with your Jinfo analyst.
Measure your starting point to articulate your strengths and set priorities for future improvements. Assessments gauge risk, capacity, value and more.
Read case studies, and start the conversation:
Connect your team with the practical tools, original research and expertise to build and support information strategy in your organisation.
A Jinfo Subscription gives access to all Content (articles, reports, webinars) and Community.